Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Queensland Health
Fuji
QuintilesIMS
Argus Health
AstraZeneca
Cantor Fitzgerald
Fish and Richardson
Teva

Generated: October 17, 2017

DrugPatentWatch Database Preview

Neomycin sulfate; polymyxin b sulfate; prednisolone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for neomycin sulfate; polymyxin b sulfate; prednisolone acetate and what is the scope of neomycin sulfate; polymyxin b sulfate; prednisolone acetate freedom to operate?

Neomycin sulfate; polymyxin b sulfate; prednisolone acetate
is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for neomycin sulfate; polymyxin b sulfate; prednisolone acetate.

Summary for Generic Name: neomycin sulfate; polymyxin b sulfate; prednisolone acetate

US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list19
Clinical Trials: see list1,964
Drug Prices:see low prices
DailyMed Link:neomycin sulfate; polymyxin b sulfate; prednisolone acetate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
POLY-PRED
neomycin sulfate; polymyxin b sulfate; prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC050081-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Queensland Health
UBS
Moodys
Dow
QuintilesIMS
Teva
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot